News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sacks Natalie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/23/2023 |
4
| Sacks Natalie (Director) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Granted 21,500 options to buy
@ $6.12, valued at
$131.6k
|
|
| 12/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 155,000 options to buy
@ $5.03, valued at
$779.7k
|
|
| 12/21/2021 |
4
| Sacks Natalie (Director) has filed a Form 4 on Caribou Biosciences, Inc.|
Txns:
| Granted 27,500 options to buy
@ $15.16, valued at
$416.9k
|
|
| 11/15/2021 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 155,000 options to buy
@ $7.73, valued at
$1.2M
|
|
| 07/22/2021 |
3
| Sacks Natalie (Director) has filed a Form 3 on Caribou Biosciences, Inc. |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $18.66, valued at
$1.5M
|
|
| 05/20/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 1,522 shares
@ $14.7691, valued at
$22.5k
Exercised 1,522 options to buy
@ $2.12, valued at
$3.2k
|
|
| 05/12/2020 |
4
| Sacks Natalie (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 9,000 options to buy
@ $35.49, valued at
$319.4k
|
|
| 05/05/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 5,826 shares
@ $12.0668, valued at
$70.3k
Exercised 5,826 options to buy
@ $2.12, valued at
$12.4k
|
|
| 04/17/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 500 shares
@ $12, valued at
$6k
Sold 1,021 shares
@ $12.0765, valued at
$12.3k
Exercised 500 options to buy
@ $2.12, valued at
$1.1k
Exercised 1,021 options to buy
@ $2.12, valued at
$2.2k
|
|
| 04/15/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 4,556 shares
@ $12.063, valued at
$55k
Exercised 4,556 options to buy
@ $2.12, valued at
$9.7k
|
|
| 04/08/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 700 shares
@ $12.0014, valued at
$8.4k
Sold 570 shares
@ $12, valued at
$6.8k
Exercised 700 options to buy
@ $2.12, valued at
$1.5k
Exercised 570 options to buy
@ $2.12, valued at
$1.2k
|
|
| 03/18/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 1 shares
@ $12, valued at
$12
Sold 1,520 shares
@ $12, valued at
$18.2k
Exercised 1 options to buy
@ $2.12, valued at
$2.1
Exercised 1,520 options to buy
@ $2.12, valued at
$3.2k
|
|
| 03/03/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 5,826 shares
@ $14.68, valued at
$85.5k
Exercised 5,826 options to buy
@ $2.12, valued at
$12.4k
|
|
| 02/20/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 1,521 shares
@ $15, valued at
$22.8k
Exercised 1,521 options to buy
@ $2.12, valued at
$3.2k
|
|
| 02/04/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 5,826 shares
@ $13.9043, valued at
$81k
Granted 75,440 options to buy
@ $13.29, valued at
$1M
Exercised 5,826 options to buy
@ $2.12, valued at
$12.4k
|
|
| 01/21/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 1,521 shares
@ $14.9408, valued at
$22.7k
Exercised 1,521 options to buy
@ $2.12, valued at
$3.2k
|
|
| 01/06/2020 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 5,826 shares
@ $14.1779, valued at
$82.6k
Exercised 5,826 options to buy
@ $2.12, valued at
$12.4k
|
|
| 12/18/2019 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 1,521 shares
@ $17.0201, valued at
$25.9k
Exercised 1,521 options to buy
@ $2.12, valued at
$3.2k
|
|
| 12/04/2019 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 5,826 shares
@ $17.98, valued at
$104.8k
Exercised 5,826 options to buy
@ $2.12, valued at
$12.4k
|
|
| 11/19/2019 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 17,252 shares
@ $13.3297, valued at
$230k
Sold 1,000 shares
@ $14, valued at
$14k
Exercised 18,252 options to buy
@ $2.12, valued at
$38.7k
|
|
| 11/05/2019 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 5,826 shares
@ $13.1654, valued at
$76.7k
Exercised 5,826 options to buy
@ $2.12, valued at
$12.4k
|
|
| 10/16/2019 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 12,452 shares
@ $13.2734, valued at
$165.3k
Sold 11,698 shares
@ $13.2058, valued at
$154.5k
Exercised 12,452 options to buy
@ $2.12, valued at
$26.4k
Exercised 11,698 options to buy
@ $2.12, valued at
$24.8k
|
|
| 05/08/2019 |
4
| Sacks Natalie (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 10,000 options to buy
@ $19.11, valued at
$191.1k
|
|
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/02/2019 |
3
| Sacks Natalie (Director) has filed a Form 3 on Zymeworks Inc. |
| 09/14/2018 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 87,200 shares
@ $0
Sold 3,028 shares
@ $6.4993, valued at
$19.7k
|
|
| 09/06/2018 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Sold 4,504 shares
@ $7.1268, valued at
$32.1k
|
|
| 02/12/2018 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 174,400 options to buy
@ $6.05, valued at
$1.1M
|
|
| 12/13/2017 |
4
| Sacks Natalie (Chief Medical Officer) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 16,312 shares
@ $0 |
|
| 09/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|